LC
Longitude Capital
Venture CapitalActiveLongitude Capital is a California-based venture capital firm that invests in biotechnology and medical technology companies.
79
Investments
9
Exits
$2.5B
AUM
11.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Longitude Capital.
Investment Thesis & Strategy
Longitude Capital invests in biotechnology and medical technology companies across various stages, seeking to support innovative solutions in the healthcare sector.
Investment Activity
Deals per year over the last 8 years
2
20121
20131
20143
20151
20161
20172
20181
2019Portfolio Companies
Selected investments from their portfolio of 79 companies
V
Verve Therapeutics
Biotech · Series A, 2019
V
Vaxcyte
Biotech · Series A, 2018
C
Cerevel Therapeutics
Biotech · Series A, 2018
P
Pear Therapeutics
Healthcare · Series B, 2017
O
Outset Medical
Healthcare · Series B, 2016
S
Second Genome
Biotech · Series B, 2015
R
Revolution Medicines
Biotech · Series A, 2015
V
Vascular Dynamics
Healthcare · Series C+, 2015
S
SI-BONE
Healthcare · Series C+, 2014
A
Aimmune Therapeutics
Biotech · Series B, 2013
H
HeartFlow
Healthcare · Series C+, 2012
P
Prothena
Biotech · Series A, 2012
Notable Exits
CompanyTypeYearValue / Acquirer
ObsidioAcquisition2024—
Second GenomeAcquisition2023—
Verve TherapeuticsIPO2023$1.6B
Outset MedicalIPO2020$1.5B
Livongo HealthAcquisition2020$18.5B
Proclara BiosciencesAcquisition2020—
Spark TherapeuticsAcquisition2019$4.3B
SI-BONEIPO2018$500M
Proteon TherapeuticsIPO2014$100M
Frequently Asked Questions
Longitude Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals
Khosla Ventures
Menlo Park, United States · 769 deals
Greylock
Menlo Park, United States · 720 deals
GGV Capital
Menlo Park, United States · 625 deals